Clinical research organisation (CRO) Icon has begun the integration of Medidata Clinical Data Studio into its clinical ...

ECURE previously announced that the first patient dosed with ECUR-506 for OTC deficiency achieved a complete clinical ...

MacroGenics stated that although it has dropped vobra duo, it remains optimistic about its other candidate MGC026.

Onctura has dosed the first subject in the Phase II OCULE-01 trial of oral roginolisib in individuals with metastatic uveal ...

The US is set to withdraw from the WHO following Trump's disagreements regarding the agency's handling of the Covid-19 ...

IGC Pharma has added HHS in Canada as a new clinical site for its Phase II CALMA trial of IGC-AD1 to treat agitation in ...

Monte Rosa has unveiled new data from two trials of its pipeline of molecular glue degraders, notably MRT-6160 and MRT-23.

Regenxbio has reported positive interim data from the Phase I/II portion of its Affinity Duchenne study, which is examining ...

Investigators said that the OLE study showed Roche’s gantenerumab dropped the risk of developing Alzheimer's symptoms by 50%.

Flatiron Health has announced a partnership with NRG Oncology to implement the Flatiron Clinical Pipe in a multicentre NRG ...

Of the 103 patients who completed the Phase III trial, more than half saw remission from a drug-induced condition.

Innovent and HUTCHMED received conditional approval for the combo in endometrial cancer from China’s NMPA last year.